News
US President Donald Trump has threatened to impose tariffs of up to 20% on drug imports to boost manufacturing in America and ...
The move is the latest by a drugmaker as Trump threatens to impose import tariffs on the industry. Read more at ...
The British pharmaceutical giant's announcement comes amid a looming deadline for increased tariffs from Washington.
The US accounted for more than 40% of AstraZeneca's annual revenue in 2024, and the company had been prioritising the market - the world's largest, worth $635 billion - before Trump's return to office ...
British pharmaceutical giant AstraZeneca said Tuesday it would invest $50 billion in the US amid a looming deadline of ramped ...
British pharmaceutical giant AstraZeneca said Tuesday it would invest $50 billion in the United States amid a looming ...
AstraZeneca ( AZN) said it is investing $50 billion in U.S. manufacturing by 2030, following the lead of big pharma peers ...
The $50 billion target, which AstraZeneca plans to meet by 2030, includes new manufacturing projects in Virginia and ...
Nuevo León continues to attract investment to its auto sector, but some companies are now skipping investment announcements, ...
Brazil's Supreme Court Justice Alexandre de Moraes approved an investigation into possible insider trading linked to the announcement of U.S. tariffs on Brazilian imports. The probe is part of a ...
April 9: Trump's higher "reciprocal tariffs" begin just after midnight. Hours later, the president says he is issuing a 90-day pause on those duties, except for China. Trump raises tariffs on Chinese ...
Trump has sent letters to leaders of dozens of countries outlining the tariff levels set to begin on Aug. 1. In recent months ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results